Direct Investments

Developments in healthcare provision and technology

Dr Isabel Dodd. Isabel has a range of experience in the drug development sector from early-stage research companies through to GMP manufacture and clinical trials. She holds a PhD in Molecular Virology and a degree in Biochemistry and Molecular Biology.

Dr Isabel Dodd talks exclusively to Investment Week about developments in healthcare provision and technology.  In this article Isabel looks at the key themes investors should look out for in the life sciences arena and the significant progress in the life sciences industry.

You can read the full article here.